Back to Peptide Pedia
Cosmetic & Skin
Well Researched

Melanotan II

MT-2

Cyclic melanocortin agonist studied in pigmentation.

Also known as: Melanotan-2, MT-II

Research dose range0.25–1 mg (research models)
Route studiedSubcutaneous
Study durationLoading then maintenance
Storage2–8 °C reconstituted

Overview

Melanotan II is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone studied in pigmentation, melanocortin-pathway, and behavioral research.

Key research findings

A cyclic, non-selective melanocortin-receptor agonist studied for stimulating melanogenesis (tanning) with minimal sun exposure. Because it also activates MC4R, research notes appetite suppression and pronounced libido/erectile effects — the basis for the later development of PT-141.

Mechanism of action

Non-selectively activates melanocortin receptors (MC1R and MC4R), influencing melanogenesis and central pathways.

Molecular information

Weight1,024 Da
Length7 amino acids (cyclic)
TypeNon-selective melanocortin agonist
Amino-acid sequenceAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2

A cyclized, more stable and potent analog than Melanotan I; activates MC1R and MC4R.

Pharmacokinetics

Peak: ~1 hourHalf-life: ~1–2 hoursCleared: ~24 hours
Peak · 1hHalf-life · 5h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Pigmentation and melanogenesis research
  • Melanocortin-pathway studies
  • Behavioral investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Loading referenceAmount: 0.25–0.5 mgFrequency: Daily until desired toneRoute: Subcutaneous
Maintenance referenceAmount: 0.5–1 mgFrequency: 1–2× weeklyRoute: Subcutaneous

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Week 1–2

    Onset of melanogenesis/pigmentation; appetite and libido effects reported.

  2. Week 2–6

    Tanning builds; maintenance dosing sustains pigmentation in research.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

Melanotan I

Overlapping melanocortin activity — redundant.

Avoid combination

PT-141

Derived from MT-II; overlapping melanocortin/libido effects.

Use caution

BPC-157

No known interactions - different mechanisms of action and receptor targets

Compatible

Growth Hormone Peptides

No documented interactions - work through different pathways (GHRH/ghrelin vs melanocortin)

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Avoid shaking to preserve the peptide.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved into a clear solution.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Nausea, facial flushing, spontaneous erections, and darkening of moles/freckles are commonly reported.
  • Not approved for tanning use; new or changing moles warrant close monitoring in the literature.

References & further reading

Melanotan II: melanocortin agonism, pigmentation and sexual effects (review)

Preclinical/humanMC1R/MC4Rmelanogenesis

Review of the non-selective melanocortin agonist's tanning, appetite, and sexual-function effects.

View study

Topics

melanocortinpigmentationskin

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Well Researched

Substantial peer-reviewed research across multiple models.

Quick reference
Dose range0.25–1 mg (research models)
RouteSubcutaneous
DurationLoading then maintenance
Storage2–8 °C reconstituted
Half-life~1–2 hours
Available at Reviva

Melanotan II is stocked as a research-grade compound, ≥99% by HPLC, third-party verified.

View in catalogue